Compare Fox Corp Class B (FOX) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class B vs Inovio Pharmaceuticals Inc — how do they compare? Fox Corp Class B trades at $55.42 (market cap $24.58B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Fox Corp Class B is far larger — about 312.9× Inovio Pharmaceuticals Inc's market cap, and Fox Corp Class B pays a 1.05% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| FOX | INO | |
|---|---|---|
Market Cap | $24.58B | $78.55M |
Sector | Media | Health |
52-Week High | $67.76 | $2.87 |
52-Week Low | $44.39 | $0.66 |
Enterprise Value | $27.94B | $49.56M |
Dividend Yield | 1.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
